Skip to content

The effect of remimazolam on postoperative delirium in elderly patients with colorectal cancer

The effect of remimazolam on postoperative delirium in elderly patients with colorectal cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110008
Enrollment
Unknown
Registered
2025-09-28
Start date
2024-03-07
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal neoplasm surgery

Interventions

Trial group:Induction of anesthesia with remimazolam at 0.30 mg/kg and continuous infusion of remimazolam at 0.2-1.0mg/kg/h for maintenance of anesthesia.
Control group:Anesthesia induction with 2 mg/kg of propofol and continuous infusion of 3-10mg/kg/h of propofol for anesthesia maintenance.

Sponsors

Yibin Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with colorectal cancer via colonoscopy and pathological examination, and scheduled for elective laparoscopic radical resection of colorectal cancer; 2. Age >= 65 years; 3. Body Mass Index (BMI) between 18.5 kg/m^2 and 24 kg/m^2 (inclusive); 4. No known history of delirium prior to surgery; 5. American Society of Anesthesiologists (ASA) physical status classification: I-III; 6. Mini-Mental State Examination (MMSE) score >= 25; 7. Patients have provided informed consent for participation in the study.

Exclusion criteria

Exclusion criteria: 1. Those with severe functional disorders of important organs such as the heart, brain, lungs, liver and kidneys; 2. Those with a history of neurological or mental disorders, long-term use of sedative-hypnotic or antipsychotic drugs, or long-term stress stimulation or psychological disorders; 3. History of alcohol abuse and dependence on painkillers; 4. Those who are allergic to the drugs used in the research; 5. Those with a history of abnormal anesthesia or surgical recovery in the past; 6. Emergency surgery; 7. Patients who cannot cooperate; 8. Recently or currently participating in other clinical research.

Design outcomes

Primary

MeasureTime frame
Postoperative delirium;

Secondary

MeasureTime frame
Severity, duration, and subtyping of postoperative delirium;Mean arterial pressure;Heart Rate;Inflammatory markers (including interleukin-6 levels, interleukin-1ß, and neutrophil-to-lymphocyte ratio);Recovery time of spontaneous breathing;The recovery time of orientation;Extubation time;

Countries

China

Contacts

Public ContactXu Jian

Yibin Second People's Hospital

410894154@qq.com+86 182 0820 2484

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026